Hemostatic and antifibrinolytic agent
PCP: Signs of shock or hypoperfusion, in association with an injury suggestive of occult or ongoing hemorrhage
Prevents clot degradation by competing for TPA receptor sites.
May potentiate hypotension if administered too quickly
For intravenous infusion use only. Do not administer as a push dose, intramuscularly, or subcutaneously.